Drugs / Sorbolene
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00193908 | Mar 2004 → Sep 2007 | breast cancer | Trans Tasman Radiation Oncology Group | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sorbolene | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00193908 ↗ |
| Route | Topical | “Sorbolene will be applied to either the medial or the lateral side of the treated breast.” NCT00193908 ↗ |